SENSIENT (SXT) director buys 1,000 shares at $91.2575 on 11/03/2025

Sensient Technologies (SXT) Form 4: A director reported an open‑market purchase of 1,000 shares of Common Stock on 11/03/2025 at a price of $91.2575 per share (Code P).

Accepted by SEC EDGAR 11/03/2025 - 04:27 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Sensient Technologies (SXT) Form 4: A director reported an open‑market purchase of 1,000 shares of Common Stock on 11/03/2025 at a price of $91.2575 per share (Code P). Following this transaction, the director beneficially owns 22,414.266 shares directly. The filing also lists 22,776.623 deferred stock units, which convert to Common Stock on a one‑for‑one basis, with shares issued upon the director’s termination of service.

Insider Trade Summary

Net Buyer: 1,000 shares

Net Buy 1 txn

Insider Carleone Joseph

Role Director

Bought 1,000 shs ($91K)

Increase in Position 4.7%

Type	Security	Shares	Price	Value
Purchase	Common Stock	1,000	$91.2575	$91K
Holding	Deferred Stock	--	--	--

Holdings After Transaction: Common Stock — 22,414.266 shares (Direct); Deferred Stock — 22,776.623 contracts (Direct)

Holdings Before and After: Common Stock, 21,414.266 to 22,414.266 shares (Direct)

Footnotes (3)

1. F1. Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan.
2. F2. Deferred stock converts to common stock on a one-for-one basis.
3. F3. Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did SXT disclose?

A director purchased 1,000 shares of Common Stock on 11/03/2025 at $91.2575 per share (Code P).

How many SXT shares does the director own after the trade?

Direct beneficial ownership is 22,414.266 shares following the reported transaction.

What derivative holdings were reported for SXT?

The filing reports 22,776.623 deferred stock, convertible to Common Stock on a one‑for‑one basis.

When will the deferred stock convert into SXT common shares?

Per the filing, shares of Common Stock will be issued upon the director’s termination of service.

What does transaction code 'P' mean in the SXT Form 4?

Code P indicates an open‑market purchase of the issuer’s equity.

Is the SXT purchase reported as direct or indirect ownership?

The 22,414.266 shares are reported under Direct (D) ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Carleone Joseph

(Last) (First) (Middle)

777 EAST WISCONSIN AVENUE

(Street)

MILWAUKEE WI 53202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SENSIENT TECHNOLOGIES CORP [ SXT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/03/2025		P		1,000	A	$91.2575	22,414.266(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock	(2)							(3)	(3)	Common Stock	22,776.623		22,776.623	D

Explanation of Responses:

1. Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan.

2. Deferred stock converts to common stock on a one-for-one basis.

3. Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer.

	/s/ John J. Manning, Attorney-in-Fact for Dr. Carleone	11/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.